OWP
TEVA icon

ORG Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History

ORG Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Hold
844
– – ﹤0.01% 407
2026
Q1 		$25.4K Buy
844
+171
+25% +$5.5K 0.01% 389
2025
Q4 		$21K Buy
673
+173
+35% +$4.26K ﹤0.01% 399
2025
Q3 		$10.1K Hold
500
– – ﹤0.01% 471
2025
Q2 		$8.32K Sell
500
-198
-28% -$3.19K ﹤0.01% 508
2025
Q1 		$10.7K Buy
698
+485
+228% +$8.66K ﹤0.01% 531
2024
Q4 		$4.69K Hold
213
– – ﹤0.01% 420
2024
Q3 		$3.84K Buy
+213
New +$3.73K ﹤0.01% 417

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

ORG Wealth Partners's TEVA Position: Q2 2026 in Review

ORG Wealth Partners held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 844 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

ORG Wealth Partners first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • ORG Wealth Partners held 844 shares of Teva Pharmaceuticals worth $28.6K as of Q2 2026.
  • ORG Wealth Partners left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of ORG Wealth Partners's portfolio in Q2 2026, its #407 holding.
  • ORG Wealth Partners first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.